<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Investigational New Drug Applications; Exemptions for Clinical Investigations To Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Investigational New Drug Applications; Exemptions for Clinical Investigations To Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic</h1>
    <p class="timestamp">Published: 2022-12-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA, the Agency, or we) is proposing to amend its regulations on investigational new drug applications (INDs) to exempt from the IND requirements certain clinical investigations of lawfully marketed foods for human consumption (including both conventional foods and dietary supplements) and cosmetics when the product is to be studied to evaluate its use as a drug. Under the proposal, clinical studies to evaluate a drug use of such products would not have to be co...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-26728</p>
    <p><strong>Publication Date:</strong> 2022-12-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/12/09/2022-26728/investigational-new-drug-applications-exemptions-for-clinical-investigations-to-evaluate-a-drug-use">https://www.federalregister.gov/documents/2022/12/09/2022-26728/investigational-new-drug-applications-exemptions-for-clinical-investigations-to-evaluate-a-drug-use</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-26728</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
